1.Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613–9.
2.Melmed S. Pathogenesis of pituitary tumors. Nat. Rev. Endocrinol. 2011;7:257-266
3.Gold EB. Epidemiology of pituitary adenomas. Epidemiol Rev. 1981;3:163-183.
4.Asa SL, Ezzat S. The pathogenesis of pituitary tumors. Annu. Rev. Pathol. 2009;4:97-126.
5.Anderson D, Faber P, Marcovitz S, Hardy J, Lorenzetti D. Pituitary tumors and the ophthalmologist. Ophthalmology. 1983;90:1265–70.
6.Garcia T, Sanchez S, Litre CF, Radoi C, Delemer B, Rousseaux P, Ducasse A, Arndt C. Prognostic value of retinal nerve fiber layer thickness for postoperative peripheral visual field recovery in optic chiasm compression. J Neurosurg. 2014; 121: 165–169.
7.Monteiro ML, Hokazono K, Fernandes DB, Costa-Cunha LV, Sousa RM, Raza AS, Wang DL, Hood DC. Evaluation of inner retinal layers in eyes with temporal hemianopic visual loss from chiasmal compression using optical coherence tomography. Invest Ophthalmol Vis Sci. 2014; 55: 3328–3336.
8.Sun M, Zhang Z, Ma C, Chen S, Chen X. Quantitative analysis of retinal layers on three-dimensional spectral-domain optical coherence tomography for pituitary adenoma. PLoS One. 2017;12(6):e179532.
9.Jeong AR, Kim EY, Kim NR. Preferential Ganglion Cell Loss in the Nasal Hemiretina in Patients With Pituitary Tumor. J Neuro-Ophthalmol 2016; 36: 152-155
10.Akashi A, Kanamor Ai, Ueda K, Matsumoto Y, Yamada Y, Nakamura M. The Detection of Macular Analysis by SD-OCT for Optic Chiasmal Compression Neuropathy and Nasotemporal Overlap. Invest Ophthalmol Vis Sci. 2014; 55:4667–4672.
11.Blanch RJ, Micieli JA, Oyesiku NM, Newman NJ, Biousse V. Optical coherence tomography retinal ganglion cell complex analysis for the detection of early chiasmal compression. Pituitary. 2018; 21:515-523.
12.Beltrame S, Rasmussen J, Plou P, Altszul M, Yampolsky C, Ajler P. Optical coherence tomography as a predictor of visual recovery in patients with pituitary macroadenomas. Surg Neurol Int. 2018;13; 9: S57-S65.
13.Danesh-Meyer HV, Wong A, Papchenko T, Matheos K, Stylli S, Nichols A, Frampton C, Daniell M, Savino PJ, Kaye AH. Optical coherence tomography predicts visual outcome for pituitary tumors. J Clin Neurosci. 2015; 22:1098-104.
Kawaguchi T, Ogawa Y, Tominaga T. Retinal nerve fiber layer thickness measurement for predicting visual outcome after transsphenoidal surgery: optic disc atrophy is not the deciding indicator. World Neurosurg. 2019;127: e427-e435
15.Glebauskiene B, Liutkeviciene R, Zlatkute E, Kriauciuniene L, Zaliuniene D. Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients. J Clin Neurosci. 2018;50:1-6.
16.Wang X, Li S, Fu J, Wu G, Mu D, Li S, Wang J, Wang N. Comparative study of retinal nerve fibre layer measurement by RTVue OCT and GDx VCC. Br J Ophthalmol. 2011; 95:509-13.
17.Cennamo G, Auriemma RS, Cardone D, Gardone D, Grasso LF, Velotti N, Simeoli C, Di Somma C, Pivonello R, Colao A, de Crecchio G. Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression. Eye (Lond). 2015;29:797-802.
18.Ventura LM, Venzara FX III, Porciatti V. Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumors. Doc Ophthalmol. 2009; 118:155–162
19.McIlwaine GG, Carrim ZI, Lueck CJ, Chrisp TM. A mechanical theory to account for bitemporal hemianopia from chiasmal compression. J Neuroophthalmol. 2005;25:40-43.
20.Abouaf L, Vighetto A, Lebas M. Neuro-ophthalmologic exploration in non-functioning pituitary adenoma. Ann Endocrinol (Paris). 2015;76(3):210-9.
21.Bergland R. The arterial supply of the human optic chiasm. J Neurosurg. 1969;31:327-334.
22.Dawson BH. The blood vessels of the human optic chiasma and their relation to those of the hypophysis and hypothalamus. Brain.1958; 81(2):207–217
23.Lachowicz E, Lubiński W. The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview. Doc Ophthalmol. 2018; 137:193-202.
24.Gutowski NJ, Heron JR, Scase MO. Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours. Vis Res. 1997; 37:1401–1408
25.Cioffi GA. Ischemic model of optic nerve injury. Trans Am Ophthalmol Soc.2005; 103:592–613